REALICE OPENLABEL · CVL-865-SZ-002
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A 57-WEEK, MULTICENTER, ACTIVE-TREATMENT, OPEN-LABEL EXTENSION TRIAL OF CVL-865 AS ADJUNCTIVE THERAPY IN ADULTS WITH DRUG-RESISTANT FOCAL ONSET SEIZURES EudraCT2019-004057-83
Sponsor: CEREVEL
Phase: II
Area: Epilepsy